BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 32776758)

  • 1. The Diagnostic Value of Autoantibodies to Asialoglycoprotein Receptor Combined with Antinuclear Antibody in Autoimmune Hepatitis.
    Zhuang Z; Li K; Yu Y
    Clin Lab; 2020 Aug; 66(8):. PubMed ID: 32776758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autoantibodies to asialoglycoprotein receptor (ASGPR) measured by a novel ELISA--revival of a disease-activity marker in autoimmune hepatitis.
    Hausdorf G; Roggenbuck D; Feist E; Büttner T; Jungblut PR; Conrad K; Berg C; Klein R
    Clin Chim Acta; 2009 Oct; 408(1-2):19-24. PubMed ID: 19576873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoantibodies to asialoglycoprotein receptor (ASGPR) in patients with autoimmune liver diseases.
    Villalta D; Mytilinaiou MG; Elsner M; Hentschel C; Cuccato J; Somma V; Schierack P; Roggenbuck D; Bogdanos DP
    Clin Chim Acta; 2015 Oct; 450():1-5. PubMed ID: 26220739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autoantibodies to asialoglycoprotein receptor in chronic hepatitis C patients.
    Husa P; Chalupa P; Stroblová H; Husová L; Slesinger P; Zajíc J
    Acta Virol; 2001 Feb; 45(1):7-11. PubMed ID: 11394582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Diagnostic value of autoantibodies to asialoglycoprotein receptor in autoimmune hepatitis].
    Sagynbaeva VÉ; Lazebnik LB; Vinnitskaia EV; Dorofeev AS; Efremov LI
    Eksp Klin Gastroenterol; 2013; (8):45-9. PubMed ID: 24933948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosing autoimmune hepatitis in nonalcoholic fatty liver disease: is the International Autoimmune Hepatitis Group scoring system useful?
    Yatsuji S; Hashimoto E; Kaneda H; Taniai M; Tokushige K; Shiratori K
    J Gastroenterol; 2005 Dec; 40(12):1130-8. PubMed ID: 16378177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Demographics of anti-asialoglycoprotein receptor autoantibodies in autoimmune hepatitis.
    Treichel U; McFarlane BM; Seki T; Krawitt EL; Alessi N; Stickel F; McFarlane IG; Kiyosawa K; Furuta S; Freni MA
    Gastroenterology; 1994 Sep; 107(3):799-804. PubMed ID: 8076767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The role of selected serologic markers in the diagnosis of autoimmune hepatitis].
    Marcinkiewicz M; Gryc E; Kreczko S
    Przegl Lek; 1998; 55(11):614-8. PubMed ID: 10216378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Organ and non-organ specific autoantibody titres and IgG levels as markers of disease activity: a longitudinal study in childhood autoimmune liver disease.
    Gregorio GV; McFarlane B; Bracken P; Vergani D; Mieli-Vergani G
    Autoimmunity; 2002 Dec; 35(8):515-9. PubMed ID: 12765477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Autoantibodies characteristic for autoimmune hepatitis found in chronic hepatitis C].
    Pavić S; Simonović J; Boricić I; Svirtlih N
    Srp Arh Celok Lek; 2003; 131(11-12):437-42. PubMed ID: 15114784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-asialoglycoprotein receptor autoantibodies, detected by a capture-immunoassay, are associated with autoimmune liver diseases.
    Yoshioka M; Mizuno M; Morisue Y; Shimada M; Hirai M; Nasu J; Okada H; Sakaguchi K; Yamamoto K; Tsuji T
    Acta Med Okayama; 2002 Apr; 56(2):99-105. PubMed ID: 12002624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Update of the simplified criteria for autoimmune hepatitis: Evaluation of the methodology for immunoserological testing.
    Galaski J; Weiler-Normann C; Schakat M; Zachou K; Muratori P; Lampalzer S; Haag F; Schramm C; Lenzi M; Dalekos GN; Lohse AW
    J Hepatol; 2021 Feb; 74(2):312-320. PubMed ID: 32730794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A retrospective study on the role of antibodies against soluble liver antigen (anti-SLA antibodies) and other autoantibodies in the diagnostics of autoimmune hepatitis].
    Bakker-Jonges LE; ter Borg PC; van Buuren HR; Hooijkaas H
    Ned Tijdschr Geneeskd; 2006 Mar; 150(9):490-4. PubMed ID: 16553048
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Characteristics of clinical and laboratory indexes in patients with liver disease with positive anti-liver cytosol antibody].
    Zhang HP; Yan HP; Lou JL; Huang CY; Ma YX; Li LJ; Han Y; Liu YM
    Zhonghua Gan Zang Bing Za Zhi; 2021 Dec; 29(12):1182-1187. PubMed ID: 35045634
    [No Abstract]   [Full Text] [Related]  

  • 15. Autoimmune liver disease serology in acute hepatitis E virus infection.
    Terziroli Beretta-Piccoli B; Ripellino P; Gobbi C; Cerny A; Baserga A; Di Bartolomeo C; Bihl F; Deleonardi G; Melidona L; Grondona AG; Mieli-Vergani G; Vergani D; Muratori L;
    J Autoimmun; 2018 Nov; 94():1-6. PubMed ID: 30336842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Asialoglycoprotein receptor (ASGPR) as target autoantigen in liver autoimmunity: lost and found.
    Rigopoulou EI; Roggenbuck D; Smyk DS; Liaskos C; Mytilinaiou MG; Feist E; Conrad K; Bogdanos DP
    Autoimmun Rev; 2012 Dec; 12(2):260-9. PubMed ID: 22571878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum autoantibodies in chronic hepatitis C: comparison with autoimmune hepatitis and impact on the disease profile.
    Cassani F; Cataleta M; Valentini P; Muratori P; Giostra F; Francesconi R; Muratori L; Lenzi M; Bianchi G; Zauli D; Bianchi FB
    Hepatology; 1997 Sep; 26(3):561-6. PubMed ID: 9303483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Serum autoantibodies of patients with chronic hepatitis C and the significance thereof in infection of hepatitis C virus].
    Wu CH; Xu XY; Tian GS; Yu YY
    Zhonghua Yi Xue Za Zhi; 2006 Feb; 86(6):390-3. PubMed ID: 16677548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical significance of autoantibodies in autoimmune hepatitis.
    Liberal R; Mieli-Vergani G; Vergani D
    J Autoimmun; 2013 Oct; 46():17-24. PubMed ID: 24016388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Seroprevalence of AIH-related autoantibodies in patients with acute hepatitis E viral infection: a prospective case-control study in China.
    Wu J; Guo N; Zhu L; Zhang X; Xiong C; Liu J; Xu Y; Fan J; Yu J; Pan Q; Yang J; Liang H; Jin X; Ye S; Wang W; Liu C; Zhang J; Li G; Jiang B; Cao H; Li L
    Emerg Microbes Infect; 2020; 9(1):332-340. PubMed ID: 32037983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.